Aminolysis of the 2H-pyran-2-ylidenetungsten
complex 3 affords amino-1-tungsta-1,3,5-hexatrienes with different structures, depending on the reaction
temperature and the type
of amine involved. Addition of primary amines RNH2
(4a
−
d) (R = allyl,
n-Bu, CH2Ph, i-Pr)
to 3 at −15 °C yields salt-type
(3Z)-6-amino-1-tungsta-1,3,5-hexatrienes
5a
−
d by reversible
ring opening of the pyranylidene ring. Addition of
4a
−
c at 20 °C affords
(3Z)-2-amino-1-tungsta-1,3,5-hexatrienes 6a
−
c by an
irreversible ring opening of the pyranylidene ring.
Secondary amines RR1NH
8a
−
c [RR1N =
Me2N, 2-(hydroxymethyl)pyrrolidine,
pyrrolidine]
undergo an irreversible ring opening to
2-amino-1-tungsta-1,3,5-hexatrienes
9a
−
c. Aminolysis of 3 in the presence of
Me3SiCl/Et3N affords acetimino
pyranylidene complexes 10,
from which (3Z)-2,6-diamino-1-tungsta-1,3,5-hexatrienes
11 are derived upon aminolysis.
Thermolysis of 6a in THF/pyridine affords the
captodative 1-amino-1,3-hexadien-5-one 12.
2H-Pyran-2-ylidene complex 3,
C19H12O7W, was characterized by
X-ray diffraction.
Addition of tertiary open-chain enamines R 1 HCdC(NR 2 )Me 7a-e [NR 2 ) pyrrolidine, N(i-Bu) 2 ; R 1) Ph, CO 2 Me, CO 2 Et, CO 2 Bz, CO 2 -t-Bu] to the 1-alkynylcarbene complex (CO) 5 WdC-(OEt)CtCPh (1a) affords novel (1-azoniabutadien-4-yl)carbonylmetalates ( -OC) 5 WC-(OEt)dC[C(dN + R 2 )Me]C(Ph)dCHR 1 (2E)-torquo-8a-f by dichotomy of the CdC(N) bond of 8 at the CtC bond of 1. Compounds (2E)-torquo-8 are stable in solid state but undergo (2E/2Z) isomerization in solution to give compounds (2Z)-torquo-8. X-ray structure analyses are reported of compounds (2E)-torquo-8e, (2E)-torquo-8f, and (2Z)-torquo-8a.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.